CDC Has Detected A New Sars-COV-2 Variant Labeled BA.2.86; Based On What CDC Knows Now, Existing Tests Used To Detect And Medications Used To Treat Covid-19 Appear To Be Effective With Variant BA.2.86
Portfolio Pulse from Benzinga Newsdesk
The CDC has detected a new Sars-COV-2 variant labeled BA.2.86. Based on current knowledge, existing tests and medications used to treat Covid-19 appear to be effective with this variant.
August 23, 2023 | 3:28 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
AstraZeneca's Covid-19 tests and treatments may remain effective against the new variant BA.2.86.
The news that existing tests and treatments are effective against the new variant is positive for AstraZeneca, as it suggests their products will remain relevant and in demand.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 75
POSITIVE IMPACT
BioNTech's Covid-19 tests and treatments may remain effective against the new variant BA.2.86.
The news that existing tests and treatments are effective against the new variant is positive for BioNTech, as it suggests their products will remain relevant and in demand.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 75
POSITIVE IMPACT
Johnson & Johnson's Covid-19 tests and treatments may remain effective against the new variant BA.2.86.
The news that existing tests and treatments are effective against the new variant is positive for Johnson & Johnson, as it suggests their products will remain relevant and in demand.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 75
POSITIVE IMPACT
Moderna's Covid-19 tests and treatments may remain effective against the new variant BA.2.86.
The news that existing tests and treatments are effective against the new variant is positive for Moderna, as it suggests their products will remain relevant and in demand.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 75
POSITIVE IMPACT
Novavax's Covid-19 tests and treatments may remain effective against the new variant BA.2.86.
The news that existing tests and treatments are effective against the new variant is positive for Novavax, as it suggests their products will remain relevant and in demand.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 75
POSITIVE IMPACT
Pfizer's Covid-19 tests and treatments may remain effective against the new variant BA.2.86.
The news that existing tests and treatments are effective against the new variant is positive for Pfizer, as it suggests their products will remain relevant and in demand.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 75